(Q83798645)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Surveillance of vaccine safety: comparison of parental reports with routine surveillance and a clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

Eva Netterlid

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Marie Edwinson Månsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Anders Håkansson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

6 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

2042-2047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

Adverse events following immunisation: desperately seeking surveillance

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Understanding variation in measles-mumps-rubella immunization coverage--a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

The Vaccine Adverse Event Reporting System (VAERS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

The role of aluminium for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Is the cultural context of MMR rejection a key to an effective public health discourse?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

An internet-based survey on parental attitudes towards immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Parents' reported reasons for avoiding MMR vaccination. A telephone survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Patterns of vaccination acceptance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.01.131

10.1016/J.VACCINE.2009.01.131

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19428828%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference